Vycor Medical (VYCO) Other Accumulated Expenses (2010 - 2025)
Vycor Medical's (VYCO) quarterly Other Accumulated Expenses came in at $88429.0 in Q2 2025, down 44.69% year-on-year from $159886.0 in Q2 2024, and down 29.94% on a QoQ basis from $126212.0 in Q1 2025.
Vycor Medical (VYCO) Other Accumulated Expenses (2010 - 2025) Analysis & Trends
Vycor Medical (VYCO) has 15 years of Other Accumulated Expenses data on file, last reported at $88429.0 in Q2 2025.
- On a quarterly basis, Other Accumulated Expenses fell 44.69% year-over-year to $88429.0 in Q2 2025; TTM through Jun 2025 was $88429.0, a 44.69% decrease from a year earlier, with the FY2024 full-year figure at $157545.0, up 3.77% from the prior year.
- Other Accumulated Expenses for Q2 2025 stood at $88429.0, down from $126212.0 in the prior quarter.
- Over the last five years, Other Accumulated Expenses for VYCO reached as high as $2.3 million in Q3 2023 and fell as low as $88429.0 in Q2 2025.
- Historically, Other Accumulated Expenses has averaged $462601.2 across 5 years, with a median of $129937.0 in 2021.
- Across the five-year window, Other Accumulated Expenses soared 2230.12% in 2023 and plunged 93.76% in 2024, its largest moves.
- Year by year, Other Accumulated Expenses stood at $126959.0 in 2021, then soared by 1432.95% to $1.9 million in 2022, then sank by 92.2% to $151816.0 in 2023, then increased by 3.77% to $157545.0 in 2024, then tumbled by 43.87% to $88429.0 in 2025.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $88429.0 in Q2 2025, $126212.0 in Q1 2025, and $157545.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 88,429.00 |
| Mar 31, 2025 | 126,212.00 |
| Dec 31, 2024 | 157,545.00 |
| Sep 30, 2024 | 187,995.00 |
| Jun 30, 2024 | 159,886.00 |
| Mar 31, 2024 | 131,532.00 |
| Dec 31, 2023 | 151,816.00 |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 128,087.00 |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 97,445.00 |
| Jun 30, 2022 | 148,322.00 |
| Mar 31, 2022 | 123,937.00 |
| Dec 31, 2021 | 126,959.00 |
| Sep 30, 2021 | 123,658.00 |
| Jun 30, 2021 | 128,342.00 |
| Mar 31, 2021 | 121,441.00 |
| Dec 31, 2020 | 117,050.00 |
| Sep 30, 2020 | 116,085.00 |